KUALA LUMPUR (Aug 30): IHH Healthcare Bhd's earnings for 2Q19 ended June 30 rose 12% to RM184.99 million ($61 million) compared to RM165.11 million a year ago, as the group continues to book in contributions from two new acquisitions that were completed in the final quarter of last year.
Aside from the boost of the Amanjaya Specialist Centre (completed last October) and Fortis Healthcare (acquired a month later) acquisitions, the better earnings was also a result of the continuous ramp up of its Gleneagles Hong Kong Hospital in Hong Kong, and the Acibadem Altunizade Hospital in Turkey, both of which opened their doors in March 2017, and sustained organic growth from other existing operations.
This pushed earnings per share to 1.86 sen from 1.75 sen, the largest hospital operator in Asia said in a stock exchange filing today.
